계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Bellicum Pharmaceuticals
company
About
Bellicum Pharmaceuticals is a clinical-stage biopharmaceutical company that is driving the future of cellular immuno-oncology (IO).
- 101 - 250
Details
- Last Funding Type
- Post-IPO Debt
- Industries
- Biotechnology,Health Care,Health Diagnostics,Therapeutics
- Founded date
- Jul 1, 2004
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Bellicum Pharmaceuticals is a clinical stage company developing next generation therapeutic vaccines and other immunotherapeutic approaches for the treatment of cancer and chronic infectious diseases. Bellicum's novel approach is to utilize precise knowledge of the signaling pathways that regulate the immune response to target specific factors that can influence the potency and duration of this response.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$1.45M
Bellicum Pharmaceuticals has raised a total of
$1.45M
in funding over 2 rounds. Their latest funding was raised on
Jan 1, 2015 from a Post-IPO Debt round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 1, 2015 | Post-IPO Debt | — | 1 | — | — | Detail |
| Oct 9, 2007 | Grant | $1.45M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Bellicum Pharmaceuticals is funded by 2 investors.
Hercules Capital
and Texas Wide Open for Business
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Hercules Capital
|
— | Post-IPO Debt |
Texas Wide Open for Business
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
